Embracing Gender Aspect In Neurology


Virtual  
Thursday, September 23, 2021 5:00 PM - 6:30 PM   Add to Calendar W. Europe Standard Time

Did you know that nearly 180 million people globally are affected by disorders of the brain and that neurological disorders are responsible for over 9 million deaths per year? Neurological disorders can affect anyone, young and old, and their impact is significant on the patient, their carers and the wider society. But how does gender determine the impact and outcome of neurological disease on the patient, families and the wider neurology community? Embracing Gender Aspect In Neurology During this interactive panel discussion, we will focus on understanding the Gender Aspects in Neurology and how each of them can be taken into consideration from a caregiver and patient perspective, and from a policy and medical perspective. We will be asking ourselves: - How important is gender diversity in research, including the structure and management of neurological clinical trials? - Is there a difference between the male and female brain that impacts the management of neurological disease? - Does the societal burden of neurological disorders equally impact men and women? - Does gender play a role in the diagnosis of neurological diseases? During this event, Roche in partnership with the Healthcare Businesswomen's Association (HBA) will have the honor of hosting Dr. Helen Fisher, an internationally-renowned neuroscientist and biological anthropologist and a pioneer in the biology of human personality and the neurochemistry of leadership (www.helenfisher.com). Featured Speakers - Dr. Helen Fisher, Biological Anthropologist, Senior Research Fellow at The Kinsey Institute and Chief Science Advisor to Match.com (Keynote speaker) - Simona Skejanec, Senior VicePresident Neuroscience and Rare Diseases, Hoffmann-La Roche (Co-facilitator) - Dr. Jan Schadrack, Global Medical Head Neuroscience and Rare Diseases, Hoffmann-La Roche (Co-facilitator) - Dr. Antonella Santuccione, Head Stakeholder Engagement Alzheimer's disease at Biogen, Pro Bono CEO and Co-founder Women's Brain Project (Panelist) - Donna Walsh, EFNA, Executive Director (Panelist) - Dr. Kathryn Wagner, Vice President of Neuromuscular Disorders (Panelist) - Lydia Lanman, Senior Global Access Policy Leader, Hoffmann-La Roche (Panelist) - Sasha Bozeat, Senior International Medical Affairs Manager Alzheimer DIA, Hoffmann-La Roche (Panelist)

HBA Basel presents

Embracing Gender Aspect In Neurology


Date and time
Thursday, 23 September
05:00PM - 06:30PM WEST
Location
Virtual

Event Contact
Gemma Masachs Martin
Competencies
3. Exhibits business and industry acumen
Event Sponsor

Did you know that nearly 180 million people globally are affected by disorders of the brain and that neurological disorders are responsible for over 9 million deaths per year?

Neurological disorders can affect anyone, young and old, and their impact is significant on the patient, their carers and the wider society. But how does gender determine the impact and outcome of neurological disease on the patient, families and the wider neurology community?

Embracing Gender Aspect In Neurology
During this interactive panel discussion, we will focus on understanding the Gender Aspects in Neurology and how each of them can be taken into consideration from a caregiver and patient perspective, and from a policy and medical perspective.

We will be asking ourselves:
- How important is gender diversity in research, including the structure and management of neurological clinical trials?
- Is there a difference between the male and female brain that impacts the management of neurological disease?
- Does the societal burden of neurological disorders equally impact men and women?
- Does gender play a role in the diagnosis of neurological diseases?

Roche in partnership with the Healthcare Businesswomen's Association (HBA) will have the honor of hosting Dr. Helen Fisher, an internationally-renowned neuroscientist and biological anthropologist and a pioneer in the biology of human personality and the neurochemistry of leadership (www.helenfisher.com).

Featured Speakers
- Dr. Helen Fisher, Biological Anthropologist, Senior Research Fellow at The Kinsey Institute and Chief Science Advisor to Match.com (Keynote speaker)
- Simona Skerjanec, Senior VicePresident Neuroscience and Rare Diseases, Hoffmann-La Roche (Co-facilitator)
- Dr. Jan Schadrack, Global Medical Head Neuroscience and Rare Diseases, Hoffmann-La Roche (Co-facilitator)
- Dr. Antonella Santuccione, Pro Bono CEO and Co-founder Women's Brain Project (Panelist)
- Donna Walsh, EFNA, Executive Director (Panelist)
- Dr. Kathryn Wagner, Vice President of Neuromuscular Disorders, Hoffmann-La Roche (Panelist)
- Lydia Lanman, Senior Global Access Policy Leader, Hoffmann-La Roche (Panelist)
- Sasha Bozeat, Senior International Medical Affairs Manager Alzheimer DIA, Hoffmann-La Roche (Panelist)


Additional Information 
Dr. Helen Fisher will be offering the opportunity to take her current NeuroColor personality questionnaire, via a link she will provide during her forthcoming presentation. This questionnaire is the only existing test derived directly from brain biology and validated using fMRI brain scanning. It is based on Fisher’s original questionnaire—now taken by over 15 million people in 40 countries. Everyone is unique. But humanity has evolved four basic styles of thinking. And as Fisher recently said in the Harvard Business Review, “When you understand how the brain works, you can reach anyone.”

Agenda 
5:00 - 5:10 PM HBA Introduction & Welcome
5:10 - 5:40 PM Helen Fisher's keynote address
5:40 - 6:10 PM Opening the Panel discussion
6:10 - 6:25 PM Q&As

Registration information
Event is open to: HBA Members and Nonmembers

Cancellations/refunds
This event is refundable, requests must be submitted in writing to events@hbanet.org by 20 September 2021

Featured Speakers

Sasha  Bozeat
Senior International Medical Affairs Manager
Roche Genentech
Lydia  Lanman

Roche Genentech
Antonella  Santuccione
CEO, WBP - Global Medical Manager for Alzheimer's disease
Biogen
Kathryn  Wagner

Roche Genentech

Registration information

The registration button at the bottom of the page will not show if online registration has closed or if the event has reached capacity. If you are a guest and the registration button is not showing, it may be that this is a member-only event. Read more about the benefits of membership or contact us about membership.

The HBA will make reasonable modifications to policies and programs to ensure that people with special needs have an equal opportunity to enjoy all of its programs. Contact us if you require special accommodations for this event.

 Price LevelRegular
Collapse group

Registration: *Regular Registration

 Member$0.00
 Member - Euro€0.00
 Non-Member$20.00
 Non-Member - Euro€17.00
Collapse group

Registration: Employees of Roche Genentech

 Member$0.00
 Member - Euro€0.00
 Non-Member$0.00
 Non-Member - Euro€0.00

By registering for this event, you acknowledge that you may be photographed, videotaped and/or audio-taped during the course of the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.